These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38928008)

  • 21. Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer's Disease: Finding Potential Therapeutic Targets.
    Song M; Fan X
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial therapeutic interventions in Alzheimer's disease.
    Van Giau V; An SSA; Hulme JP
    J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.
    Yao J; Brinton RD
    Adv Pharmacol; 2012; 64():327-71. PubMed ID: 22840752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.
    Demarest TG; Varma VR; Estrada D; Babbar M; Basu S; Mahajan UV; Moaddel R; Croteau DL; Thambisetty M; Mattson MP; Bohr VA
    Acta Neuropathol; 2020 Jul; 140(1):25-47. PubMed ID: 32333098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
    Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
    Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
    Yuan X; Wang L; Tandon N; Sun H; Tian J; Du H; Pascual JM; Guo L
    J Alzheimers Dis; 2020; 78(1):425-437. PubMed ID: 33016909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer's Disease.
    Fairley LH; Wong JH; Barron AM
    Front Immunol; 2021; 12():624538. PubMed ID: 33717134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's pathogenesis and its link to the mitochondrion.
    Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
    Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X; Yan SD
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations.
    Mani S; Swargiary G; Singh M; Agarwal S; Dey A; Ojha S; Jha NK
    Life Sci; 2021 Nov; 285():119985. PubMed ID: 34592237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome.
    Blass JP
    Ann N Y Acad Sci; 2000; 924():170-83. PubMed ID: 11193795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models.
    Fuso A; Nicolia V; Cavallaro RA; Scarpa S
    J Nutr Biochem; 2011 Mar; 22(3):242-51. PubMed ID: 20573497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.
    Wang T; Yao J; Chen S; Mao Z; Brinton RD
    Neurotherapeutics; 2020 Jan; 17(1):178-188. PubMed ID: 31664643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolong treatment with Trans-ferulic acid mitigates bioenergetics loss and restores mitochondrial dynamics in streptozotocin-induced sporadic dementia of Alzheimer's type.
    Zafeer MF; Firdaus F; Anis E; Mobarak Hossain M
    Neurotoxicology; 2019 Jul; 73():246-257. PubMed ID: 31029786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Energy metabolism and inflammation in brain aging and Alzheimer's disease.
    Yin F; Sancheti H; Patil I; Cadenas E
    Free Radic Biol Med; 2016 Nov; 100():108-122. PubMed ID: 27154981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.
    Swerdlow RH
    Antioxid Redox Signal; 2012 Jun; 16(12):1434-55. PubMed ID: 21902597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer's Disease.
    Song J; Yang X; Zhang M; Wang C; Chen L
    J Alzheimers Dis; 2021; 84(2):557-578. PubMed ID: 34602474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial dynamics and transport in Alzheimer's disease.
    Flannery PJ; Trushina E
    Mol Cell Neurosci; 2019 Jul; 98():109-120. PubMed ID: 31216425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.